Osteoblastic response in patients with non-small cell lung cancer with activating EGFR Mutations and bone metastases during treatment with EGFR kinase inhibitors.

Subjects

Subjects :

Adenocarcinoma drug therapy
Adenocarcinoma genetics
Adenocarcinoma pathology
Bone Neoplasms genetics
Bone Neoplasms secondary
Carcinoma, Non-Small-Cell Lung genetics
Carcinoma, Non-Small-Cell Lung pathology
ErbB Receptors antagonists & inhibitors
Female
Humans
Lung Neoplasms genetics
Lung Neoplasms pathology
Middle Aged
Prognosis
Survival Rate
Bone Neoplasms drug therapy
Carcinoma, Non-Small-Cell Lung drug therapy
ErbB Receptors genetics
Lung Neoplasms drug therapy
Mutation genetics
Osteoblasts drug effects
Protein Kinase Inhibitors therapeutic use

Details

Language :

English

ISSN :

1556-1380

Volume :

5

Issue :

3

Database :

MEDLINE

Journal :

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Publication Type :

Academic Journal

Accession number :

20186030

Full Text :

https://doi.org/10.1097/JTO.0b013e3181cf32aa